SRS Capital Advisors »

Protalix Biotherapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $73 39 1.90
2024-09-30 $39 39 1.03
2024-06-30 $46 39 1.18

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Schwab Strategic Tr Us Tips Etf (SCHP)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Apple (AAPL)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Protalix Biotherapeutics

Renaissance Technologies
Northern Trust
Millennium Management
GSA Capital Partners
Stratos Wealth Partners
BlackRock
Citadel Advisors
Bridgeway Capital Management
Morgan Stanley
Jane Street
Marshall Wace
Squarepoint Ops
Orin Green Financial
Point72 Asia
Commonwealth Equity Services

View all funds holding Protalix Biotherapeutics